Preclinical antitumor activity of the diindolylmethane formulation in xenograft mouse model of prostate cancer

3,3′-Diindolylmethane Improves the Viral Pneumonia Outcomes After Influenza and SARS-CoV-2 Infection in Animal Models

Safety and tolerability of DIM-based therapy designed as personalized approach to reverse prostatic intraepithelial neoplasia (PIN)

Comparative preclinical pharmacokinetics study of 3,3?-diindolylmethane formulations: is personalized treatment and targeted chemoprevention in the horizon?

Исследование фармакокинетики новой формуляции дииндолилметана на пациентках с гиперплазией эндометрия